BioSpace News Archive

Suneva® Medical, Inc., is proud to announce an exciting new partnership that will further its leadership position in regenerative aesthetics.

The American Society for Preventive Cardiology has released an official scientific statement titled: Continuity of Care and Outpatient Management for Patients With and At High Risk for Cardiovascular Disease During the COVID-19 Pandemic: A Scientific Statement.

Pulse Biosciences, Inc. (Nasdaq: PLSE) (the “Company” or “Pulse Biosciences”), a novel bioelectric medicine company, today announced that it has updated the structure, key dates and pricing terms for its previously-announced rights offering.

XBiotech Inc. (NASDAQ: XBIT) announced today that human immune donors have now been identified that can support the Company’s development of a True Human™ antibody therapy for COVID-19

Syngenta and the Analytics Society of INFORMS are proud to recognize a team from Iowa State University as the winner of the 2020 Syngenta Crop Challenge in Analytics.

HealthpointCapital, the leading private equity firm focused exclusively on musculoskeletal healthcare, today announced the acquisition of a majority stake in IlluminOss Medical, Inc. (“IlluminOss” or the “Company”).

Convalescent plasma (i.e., the component of blood known as plasma obtained from people who have recovered from COVID-19)

Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biotechnology company focused on discovering and developing novel small molecule drugs for the treatment of cancer and other life-threatening diseases, today announced that the Company’s first quarter 2020 financial results will be released on Thursday, May 7, 2020.

Lupus is a more pervasive and severe disease than many realize, as a number of its symptoms can be invisible.

Premier Research, the clinical research company that delivers outcome-focused insights which support sponsors in developing life-changing therapies, has been recognized as a 2020 CRO Leadership Award winner in the Life Science Leader program’s “Quality (Overall)” category for excellence in clinical trial research.